Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023)
Myomo (MYO) posted Non-Current Deffered Revenue of $126.0 for Q2 2023, down 59.62% on a QoQ basis from $312.0 in Q1 2023, and down 86.51% year-over-year from $934.0 in Q2 2022.
Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023) Analysis & Trends
Myomo's Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $126.0 for Q2 2023.
- Quarterly Non-Current Deffered Revenue fell 86.51% year-over-year to $126.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $126.0 (down 86.51% YoY) and the FY2022 annual result came in at $498.0, down 60.03% from the prior year.
- Non-Current Deffered Revenue was $126.0 for Q2 2023 at Myomo, down from $312.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $8700.0 in Q2 2020 and bottomed at $126.0 in Q2 2023.
- A 5-year average of $1614.1 and a median of $1495.0 in 2019 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue changed 0.0% — and 2023, when it slumped 86.51%.
- Myomo's Non-Current Deffered Revenue stood at $1495.0 in 2019, then changed by 0.0% to $1495.0 in 2020, then fell by 16.66% to $1246.0 in 2021, then tumbled by 60.03% to $498.0 in 2022, then plunged by 74.7% to $126.0 in 2023.
- Business Quant data shows MYO's Non-Current Deffered Revenue at $126.0 in Q2 2023, $312.0 in Q1 2023, and $498.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 126.00 |
| Mar 31, 2023 | 312.00 |
| Dec 31, 2022 | 498.00 |
| Sep 30, 2022 | 685.00 |
| Jun 30, 2022 | 934.00 |
| Mar 31, 2022 | 1,246.00 |
| Dec 31, 2021 | 1,246.00 |
| Sep 30, 2021 | 1,495.00 |
| Jun 30, 2021 | 1,495.00 |
| Mar 31, 2021 | 1,495.00 |
| Dec 31, 2020 | 1,495.00 |
| Sep 30, 2020 | 1,495.00 |
| Jun 30, 2020 | 8,700.00 |
| Mar 31, 2020 | 1,495.00 |
| Dec 31, 2019 | 1,495.00 |
| Sep 30, 2018 | 249.00 |
| Jun 30, 2018 | 45,496.00 |
| Mar 31, 2018 | 45,496.00 |
| Dec 31, 2017 | 44,042.00 |